Advertisement

Topics

Summit Therapeutics plc Company Profile

10:11 EDT 21st June 2018 | BioPortfolio

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease Duchenne muscular dystrophy and the infectious disease Clostridium difficile infection.


News Articles [1224 Associated News Articles listed on BioPortfolio]

Summit Therapeutics plc: Result of AGM

Summit Therapeutics plc ('Summit' or the 'Company')Result of Annual General MeetingOxford, UK, and Cambridge, MA, US, 7 June 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that...

Summit Therapeutics plc: Summit Therapeutics Files US Annual Report on Form 20F

Summit Therapeutics plc ('Summit', or the 'Company')Summit Therapeutics Files US Annual Report on Form 20-FOxford, UK, and Cambridge, MA, US, 13 April 2018 - Summit Therapeutics plc (AIM: SUMM, NA...

Summit Therapeutics plc: Summit Therapeutics to Participate in 2018 BTIG Healthcare Conference

Summit Therapeutics plc('Summit', or the 'Company')SUMMIT THERAPEUTICS TO PARTICIPATE IN 2018 BTIG HEALTHCARE CONFERENCEOxford, UK, 23 February 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: S...

Summit Therapeutics plc: Notice of 1st Quarter Results

Summit Therapeutics plc ('Summit', or the 'Company')Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2018Oxford, UK, and Cambridge, MA, US, 1 June 2018...

Summit Therapeutics ends dosing in PhaseOut DMD trial

Summit Therapeutics has completed patient-dosing in the PhaseOut DMD clinical trial, a Phase II study of ezutromid to treat patients...Read More... The post Summit Therapeutics ends dosing in PhaseOut...

Summit Therapeutics to expand clinical trials after healthy interim results

Summit Therapeutics will expand enrollment in its phase 2 clinical trials studying the effect of ezutromid treatment on Duchenne muscular dystrophy (DMD), the company said on Wednesday. The PhaseOu...

Summit Therapeutics buys Discuva for cash and stock

Expanding its infectious disease pipeline, Summit Therapeutics PLC acquired private fellow UK-based firm Discuva Ltd. for £5mm ($6.68mm) in cash and £5mm in stock (2.93mm new ordinary shares at £1....

Summit Therapeutics extends enrolment in phase 2 PhaseOut DMD study

Summit Therapeutics has opened enrolment in a planned additional group in its phase 2 open label clinical trial dubbed PhaseOut DMD for its Duchenne muscular dystrophy (DMD) drug ezutromid.

PubMed Articles [463 Associated PubMed Articles listed on BioPortfolio]

The Second Society for Simulation in Healthcare Research Summit: Beyond our Boundaries.

In this article, we report on the Second Society for Simulation in Healthcare Research Summit held in 2017. This meeting succeeded the First Research Summit from 2011 with the goal of advancing the sc...

An African cardiology summit: The World Heart Federation African Summit on Best Practices in Policy and Access to Care in 2017 concluded with the Khartoum Action Plan, to improve cardiovascular on the African continent.

Air quality and acute myocardial infarction in adults during the 2016 Hangzhou G20 summit.

To fulfill its commitment to a successful Hangzhou G20 summit (4 to 5 September 2016), the Chinese government implemented a series of measures to improve the air quality in Hangzhou. We report finding...

Ascent to the Summit of the CME Pyramid.

Conference and summit tackle opioid crisis.

Clinical Trials [152 Associated Clinical Trials listed on BioPortfolio]

Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement

Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1311 Associated Companies listed on BioPortfolio]

Summit Therapeutics plc

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadeq...

Summit Health

Founded in 1999, Summit Health is now the nation's highest rated provider of on-site wellness programs, including health screenings, immunizations, coaching, and educational seminars. This focus on qu...

Summit Corporation plc

Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadeq...

Keen-Summit Capital Partners

Keen-Summit Capital Partners LLC, located in New York, provides real estate analysis, valuation and strategic planning services, brokerage, M&A, auction services, lease restructur...

Summit Brands

Summit Brands, formerly Iron Out, Inc., was founded in Fort Wayne, Ind. in 1958. The company has since manufactured and marketed leading household cleaning brands, such as Super Iron Out, Disposer Car...

More Information about "Summit Therapeutics plc" on BioPortfolio

We have published hundreds of Summit Therapeutics plc news stories on BioPortfolio along with dozens of Summit Therapeutics plc Clinical Trials and PubMed Articles about Summit Therapeutics plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Summit Therapeutics plc Companies in our database. You can also find out about relevant Summit Therapeutics plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...


Corporate Database Quicklinks



Searches Linking to this Company Record